Top

BMC Medicine

Published in:

01-12-2021 | SARS-CoV-2 | Research article

The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories

Authors: Yang Liu, Christian Morgenstern, James Kelly, Rachel Lowe, Mark Jit, CMMID COVID-19 Working Group

Published in: BMC Medicine | Issue 1/2021

Abstract

Background

Non-pharmaceutical interventions (NPIs) are used to reduce transmission of SARS coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). However, empirical evidence of the effectiveness of specific NPIs has been inconsistent. We assessed the effectiveness of NPIs around internal containment and closure, international travel restrictions, economic measures, and health system actions on SARS-CoV-2 transmission in 130 countries and territories.

Methods

We used panel (longitudinal) regression to estimate the effectiveness of 13 categories of NPIs in reducing SARS-CoV-2 transmission using data from January to June 2020. First, we examined the temporal association between NPIs using hierarchical cluster analyses. We then regressed the time-varying reproduction number (R_t) of COVID-19 against different NPIs. We examined different model specifications to account for the temporal lag between NPIs and changes in R_t, levels of NPI intensity, time-varying changes in NPI effect, and variable selection criteria. Results were interpreted taking into account both the range of model specifications and temporal clustering of NPIs.

Results

There was strong evidence for an association between two NPIs (school closure, internal movement restrictions) and reduced R_t. Another three NPIs (workplace closure, income support, and debt/contract relief) had strong evidence of effectiveness when ignoring their level of intensity, while two NPIs (public events cancellation, restriction on gatherings) had strong evidence of their effectiveness only when evaluating their implementation at maximum capacity (e.g. restrictions on 1000+ people gathering were not effective, restrictions on < 10 people gathering were). Evidence about the effectiveness of the remaining NPIs (stay-at-home requirements, public information campaigns, public transport closure, international travel controls, testing, contact tracing) was inconsistent and inconclusive. We found temporal clustering between many of the NPIs. Effect sizes varied depending on whether or not we included data after peak NPI intensity.

Conclusion

Understanding the impact that specific NPIs have had on SARS-CoV-2 transmission is complicated by temporal clustering, time-dependent variation in effects, and differences in NPI intensity. However, the effectiveness of school closure and internal movement restrictions appears robust across different model specifications, with some evidence that other NPIs may also be effective under particular conditions. This provides empirical evidence for the potential effectiveness of many, although not all, actions policy-makers are taking to respond to the COVID-19 pandemic.

Available only for authorised users

Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. 2020;20(5):553–8.CrossRef

Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25(4):2000058.CrossRef

Hale T, Angrist N, Kira B, Petherick A, Phillips T, Webster S. Variation in government responses to COVID-19. BSG-WP-2020/032. Version 5.0. 2020. Available from: https://www.bsg.ox.ac.uk/sites/default/files/2020-05/BSG-WP-2020-032-v5.0_0.pdf. [cited 2020 May 11].

Barrot J-N, Grassi B, Sauvagnat J. Sectoral effects of social distancing. Rochester, NY: Social Science Research Network; 2020. Report No.: ID 3569446. Available from: https://papers.ssrn.com/abstract=3569446. [cited 2020 Jun 7].

Quilty BJ, Diamond C, Liu Y, Gibbs H, Russell TW, Jarvis CI, et al. The effect of inter-city travel restrictions on geographical spread of COVID-19: evidence from Wuhan, China. medRxiv. 2020;21:2020.04.16.20067504. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01712-9.

Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400.CrossRef

Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8(4):e488–96.CrossRef

Firth JA, Hellewell J, Klepac P, Kissler S, Kucharski AJ, Spurgin LG. Using a real-world network to model localized COVID-19 control strategies. Nat Med. 2020;26:1616–22. https://doi.org/10.1038/s41591-020-1036-8.

Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020,0(0). Available from: http://www.ncbi.nlm.nih.gov/pubmed/32220655. Accessed 25 Mar 2020.

10.

Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT, et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. 2020;20(6):678–88.CrossRef

11.

Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nature Human Behaviour. 2020 2020.07.06.20147199. https://www.nature.com/articles/s41562-020-01009-0.

12.

Chen X, Qiu Z. Scenario analysis of non-pharmaceutical interventions on global COVID-19 transmissions. arXiv:200404529 [physics, q-bio, stat]. 2020; Available from: http://arxiv.org/abs/2004.04529. [cited 2020 Aug 10].

13.

Hsiang S, Allen D, Annan-Phan S, Bell K, Bolliger I, Chong T, et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature. 2020;584:262–7. https://doi.org/10.1038/s41586-020-2404-8.

14.

Amer F, Hammoud S, Farran B, Boncz I, Endrei D. Assessment of Countries’ Preparedness and Lockdown Effectiveness in Fighting COVID-19. Disaster Medicine and Public Health Preparedness. 2020;1–8.

15.

Alfano V, Ercolano S. The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis. Appl Health Econ Health Policy. 2020;18(4):509–17

16.

Banholzer N, Weenen E van, Kratzwald B, Seeliger A, Tschernutter D, Bottrighi P, et al. Impact of non-pharmaceutical interventions on documented cases of COVID-19. medRxiv. 2020;2020.04.16.20062141.

17.

Bellali H, Chtioui N, Chahed M. Factors associated with country-variation in COVID-19 morbidity and mortality worldwide: an observational geographic study. medRxiv [Internet]. [cited 2020 Aug 13]; Available from: https://www.medrxiv.org/content/10.1101/2020.05.27.20114280v1.

18.

Brauner JM, Mindermann S, Sharma M, Stephenson AB, Gavenčiak T, Johnston D, et al. The effectiveness and perceived burden of nonpharmaceutical interventions against COVID-19 transmission: a modelling study with 41 countries. Science. 2020;eabd9338.

19.

Chowell G, Rothenberg R, Roosa K, Tariq A, Hyman JM, Luo R. Sub-epidemic model forecasts for COVID-19 pandemic spread in the USA and European hotspots, February-May 2020. medRxiv. 2020;2020.07.03.20146159

20.

Rey SK, Rahman MdM, Shibly KH, Siddiqi UR, Howlader A. Epidemic Trend Analysis of SARS-CoV-2 in SAARC Countries Using Modified SIR (M-SIR) Predictive Model. medRxiv [Internet]. [cited 2020 Aug 13]; Available from: https://www.medrxiv.org/content/10.1101/2020.06.29.20142513v1.

21.

Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;8:1–8.

22.

Ghosal S, Bhattacharyya R, Majumder M. Impact of complete lockdown on total infection and death rates: a hierarchical cluster analysis. Diabetes Metab Syndr. 2020;14(4):707–11.CrossRef

23.

Jüni P, Rothenbühler M, Bobos P, Thorpe KE, Costa BR da, Fisman DN, et al. Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study. CMAJ. 2020;192(21):E566–73.

24.

Karnakov P, Arampatzis G, Kičić I, Wermelinger F, Wälchli D, Papadimitriou C, et al. Data driven inference of the reproduction number (R0) for COVID-19 before and after interventions for 51 European countries. medRxiv. 2020;2020.05.21.20109314

25.

Linka K, Peirlinck M, Costabal FS, Kuhl E. Outbreak dynamics of COVID-19 in Europe and the effect of travel restrictions. Comput Methods Biomechanics Biomed Eng. 2020;0(0):1–8.

26.

Liu X. A Simple, SIR-like but Individual-Based l-i AIR Model: Application in Comparison of COVID-19 in New York City and Wuhan. Nature Human Behaviour. 2020;2020.05.28.20115121. https://www.sciencedirect.com/science/article/pii/S2211379720321288.

27.

Lonergan M, Chalmers JD. Estimates of the ongoing need for social distancing and control measures post-“lockdown” from trajectories of COVID-19 cases and mortality. Eu Respir J 2020;56(1). Available from: https://erj.ersjournals.com/content/56/1/2001483. [cited 2020 Aug 10].

28.

López L, Rodó X. The end of social confinement and COVID-19 re-emergence risk. Nature Human Behaviour. 2020;4(7):746–55

29.

McGrail DJ, Dai J, McAndrews KM, Kalluri R. Enacting national social distancing policies corresponds with dramatic reduction in COVID19 infection rates. Nature Human Behaviour. 2020;2020.04.23.20077271. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236619#:~:text=Globally%2C%20we%20find%20that%20social,a%20two%20week%20time%20period.

30.

Mishra PK, Mishra S. A deductive approach to modeling the spread of COVID-19. medRxiv. 2020;2020.03.26.20044651.

31.

Osherovich VA, Fainberg J, Osherovich LZ. Double power law for COVID-19: prediction of new cases and death rates in Italy and Spain. medRxiv. 2020;2020.05.07.20094714.

32.

Petr K, Georgios A, Fabian W, Daniel W, Costas P, Petros K. Data-driven inference of the reproduction number for COVID-19 before and after interventions for 51 European countries. Swiss Medical Weekly [Internet]. [cited 2020 Aug 13]; Available from: https://smw.ch/article/doi/smw.2020.20313.

33.

Ghosal S, Sinha B, Sengupta S, Majumder M. Frequency of testing for COVID 19 infection and the presence of higher number of available beds per country predict outcomes with the infection, not the GDP of the country - A descriptive statistical analysis. medRxiv. 2020;2020.04.01.20047373

34.

Tobías A. Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up. Science of The Total Environment. 2020;725:138539.

35.

Wang Q, Xie S, Wang Y, Zeng D. Survival-Convolution Models for Predicting COVID-19 Cases and Assessing Effects of Mitigation Strategies. medRxiv [Internet]. [cited 2020 Aug 13]; Available from: https://www.medrxiv.org/content/10.1101/2020.04.16.20067306v2.

36.

Yang P, Qi J, Zhang S, Wang X, Bi G, Yang Y, et al. Feasibility Study of Mitigation and Suppression Intervention Strategies for Controlling COVID-19 Outbreaks in London and Wuhan. Nature Human Behaviour. 2020;2020.04.01.20043794. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236857

37.

Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, et al. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. 2020;0(0). Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30785-4/abstract. [cited 2020 Nov 4].

38.

CMMID epiforecasts Core Team. [EpiForecast] Covid-19: Global summary. EpiForecast: COVID-19. Available from: https://epiforecasts.io/covid/posts/global/. [cited 2020 May 11].

39.

World Health Organization. Tracking public health and social measures: a global dataset. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/phsm. [cited 2020 Jun 7].

40.

World Bank. World Bank Country and Lending Groups – World Bank Data Help Desk. 2020. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. [cited 2020 Jun 14].

41.

Abbott S, Hellewell J, Thompson RN, Sherratt K, Gibbs HP, Bosse NI, et al. Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts. Wellcome Open Res. 2020;5:112. https://doi.org/10.12688/wellcomeopenres.16006.1.

42.

Cori A, Ferguson NM, Fraser C, Cauchemez S. A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol. 2013;178(9):1505–12.CrossRef

43.

Murtagh F, Legendre P. Ward’s hierarchical agglomerative clustering method: which algorithms implement Ward’s criterion? J Classif. 2014;31(3):274–95.CrossRef

44.

Shimodaira H. Approximately unbiased tests of regions using multistep-multiscale bootstrap resampling. Ann Stat. 2004;32(6):2616–41.CrossRef

45.

Hausman JA. Specification tests in econometrics. Econometrica. 1978;46(6):1251–71.CrossRef

46.

R Core Team. R: a language and environment for statistical computing: Vienna R Foundation for statistical Computing; 2020. Available from: http://www.R-project.org/. Accessed 25 Apr 2020.

47.

Croissant Y, Millo G. Panel data econometrics in R: the plm package. J Stat Software. 27(2):1–43.

48.

Suzuki R, Terada Y, Shimodaira H. pvclust: hierarchical clustering with P-values via multiscale bootstrap resampling. 2019. Available from: https://CRAN.R-project.org/package=pvclust.

49.

Jackson ML, Hart GR, McCulloch DJ, Adler A, Brandstetter E, Fay K, et al. Effects of weather-related social distancing on city-scale transmission of respiratory viruses. medRxiv. 2020;3:2020.03.02.20027599.

50.

Davies NG, Kucharski AJ, Eggo RM, Gimma A, Edmunds WJ, Jombart T, et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. Lancet Public Health 2020;0(0). Available from: https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30133-X/abstract. [cited 2020 Jun 24].

51.

Russell TW, Wu JT, Clifford S, Edmunds WJ, Kucharski AJ, Jit M; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study. Lancet Public Health. 2020:S2468-2667(20)30263-2. https://doi.org/10.1016/S2468-2667(20)30263-2. Epub ahead of print. PMID: 33301722

52.

Clifford S, Quilty BJ, Russell TW, Liu Y, Chan Y-WD, Pearson CAB, et al. Strategies to reduce the risk of SARS-CoV-2 re-introduction from international travellers. medRxiv. Available from: https://www.medrxiv.org/content/10.1101/2020.07.24.20161281v2. [cited 2020 Aug 10].

53.

Stockdale JE, Doig R, Min J, Mulberry N, Wang L, Elliott LT, et al. Long time frames to detect the impact of changing COVID-19 control measures. medRxiv. 2020; 2020.06.14.20131177.

54.

Wu P, Tsang TK, Wong JY, Ng TW, Ho F, Gao H, et al. Suppressing COVID-19 transmission in Hong Kong: an observational study of the first four months. Research Square. 2020.

55.

Bertozzi AL, Franco E, Mohler G, Short MB, Sledge D. The challenges of modeling and forecasting the spread of COVID-19. PNAS. 2020;117(29):16732–8.CrossRef

56.

Armario C. Colombia’s Medellin emerges as surprise COVID-19 pioneer. AP NEWS. 2020; Available from: https://apnews.com/b3f8860343323d0daeef72191b669baf. [cited 2020 Aug 13].

57.

Islam N, Sharp SJ, Chowell G, Shabnam S, Kawachi I, Lacey B, et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ. 2020;370. Available from: https://www.bmj.com/content/370/bmj.m2743. [cited 2020 Aug 11].

58.

Vaswani K. Coronavirus: The detectives racing to contain the virus in Singapore. BBC News. 2020; Available from: https://www.bbc.com/news/world-asia-51866102. [cited 2020 Jun 15].

59.

Imperial College London. COVID-19 Behaviour Tracker. Available from: http://www.coviddatahub.com/. [cited 2020 Nov 4].

Title: The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories
Authors: Yang Liu
Christian Morgenstern
James Kelly
Rachel Lowe
Mark Jit
CMMID COVID-19 Working Group
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: SARS-CoV-2
COVID-19
Published in: BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-020-01872-8

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

In for the long-haul? Seropositivity and sequelae 1 year post COVID-19

Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort

Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews

Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder

Puberty timing and markers of cardiovascular structure and function at 25 years: a prospective cohort study

Advancing the diagnosis and classification of renal cell carcinomas